FUNDAMENTALS · Fundamentals · NZ Healthcare

Summerset Group Holdings (SNZ) Fundamentals 2026 — P/E 7.5x, Revenue Analysis | SniperIQ

Summerset Group Holdings (SNZ) is a NZ-listed Healthcare company in Medical - Care Facilities with a market capitalization of A

.6B, trading at A$6.71 on the ASX. This SniperIQ fundamentals page covers Summerset Group Holdings's valuation (P/E 7.5x, P/B 0.6x), profitability (net margin 72.0%), revenue (NZD 361M in FY2025), balance-sheet quality, and AI signal context — from live market data, research only.

Market CapA
.6B
P/E (TTM)7.5x
Net Margin72.0%
Revenue (FY25)NZD 361M

Full research coverage

  • 8-Quarter Revenue & Margin Trend
  • Debt Maturity & Coverage
  • Peer Valuation Comparison
  • Free Cash Flow & Owner Earnings
  • AI Signal + Institutional Flow
  • DCF Valuation Model

Frequently Asked Questions

What is Summerset Group Holdings's market cap?

Summerset Group Holdings (SNZ) has a market capitalization of approximately A

.6B, trading at A$6.71 on the ASX. Market cap moves with the live share price.

What is Summerset Group Holdings's P/E ratio?

Summerset Group Holdings's trailing twelve-month P/E ratio is 7.5x, with a price-to-book (P/B) of 0.6x. Valuation multiples are best compared with Healthcare sector peers rather than read in isolation.

How profitable is Summerset Group Holdings?

Summerset Group Holdings runs a net profit margin of 72.0%, a gross margin of 42.8%, and an operating margin of 36.5%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.

How much revenue does Summerset Group Holdings generate?

Summerset Group Holdings reported revenue of NZD 361M for fiscal year 2025, with net income of NZD 260M and earnings per share (EPS) of 1.08. SniperIQ tracks the full 8-quarter revenue and margin trend on the research dashboard.

Does Summerset Group Holdings pay a dividend?

Summerset Group Holdings offers a trailing dividend yield of about 3.0%. Dividend sustainability depends on payout ratio, free cash flow, and earnings stability — all tracked in SniperIQ's fundamentals view.

Is Summerset Group Holdings financially healthy?

Summerset Group Holdings carries a debt-to-equity ratio of 0.60x and a current ratio of 0.34x, with a market beta of 0.31. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.

Is Summerset Group Holdings a good stock to buy in 2026?

SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For Summerset Group Holdings (SNZ) the key facts are: market cap A

.6B, P/E 7.5x, revenue NZD 361M, 52-week range 5.75-12.09. Weigh valuation, profitability, growth, and balance-sheet strength against Healthcare peers and form your own view.

Track Summerset Group Holdings's full fundamentals live

Get Summerset Group Holdings's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.

Related: Medicare Group Q.P.S.C (MCGS.QA) fundamentals · Harrow Health (HROW) fundamentals · Butterfly Network (BFLY) fundamentals · Teladoc Health (TDOC) fundamentals · All stock fundamentals · AI signal library
Research Hubs: Fundamentals library · Screeners · Institutional positioning · Super investors · Daily signals · Platform comparisons